James Gordon
Stock Analyst at JP Morgan
(2.84)
# 1,731
Out of 4,876 analysts
8
Total ratings
80%
Success rate
18.31%
Average return
Main Sectors:
Top Industries:
Stocks Rated by James Gordon
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GRFS Grifols | Maintains: Neutral | $7.6 → $10 | $8.87 | +16.12% | 1 | Jun 17, 2025 | |
| ARGX argenx SE | Maintains: Overweight | $640 → $670 | $560.14 | +19.61% | 5 | Nov 4, 2024 | |
| GMAB Genmab | Downgrades: Neutral | n/a | $20.50 | - | 1 | Aug 20, 2024 | |
| FGEN FibroGen | Upgrades: Neutral | n/a | $5.22 | - | 1 | Apr 7, 2021 |
Grifols
Jun 17, 2025
Maintains: Neutral
Price Target: $7.6 → $10
Current: $8.87
Upside: +16.12%
argenx SE
Nov 4, 2024
Maintains: Overweight
Price Target: $640 → $670
Current: $560.14
Upside: +19.61%
Genmab
Aug 20, 2024
Downgrades: Neutral
Price Target: n/a
Current: $20.50
Upside: -
FibroGen
Apr 7, 2021
Upgrades: Neutral
Price Target: n/a
Current: $5.22
Upside: -